Copyright
©The Author(s) 2021.
World J Transplant. Mar 18, 2021; 11(3): 70-86
Published online Mar 18, 2021. doi: 10.5500/wjt.v11.i3.70
Published online Mar 18, 2021. doi: 10.5500/wjt.v11.i3.70
Figure 6 Factors modified by belatacept and tacrolimus based regimen.
BPAR: Biopsy proven acute rejection; NODAT: New onset diabetes mellitus after transplantation; Serum LDL: Serum low density lipoprotein.
- Citation: Kumar J, Reccia I, Virdis F, Podda M, Sharma AK, Halawa A. Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review. World J Transplant 2021; 11(3): 70-86
- URL: https://www.wjgnet.com/2220-3230/full/v11/i3/70.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i3.70